Immunocore Holdings IMCR
NASDAQ IMCR
$30.85 +0.21 (+0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immunocore Holdings (IMCR) Share-based Compensation (2021 - 2026)

Updated

Immunocore Holdings' Share-based Compensation came in at $9.4 million for Q2 2026, down 6.3% from $10.03 million a year earlier but up 49.2% from the prior quarter.

Analysis

Immunocore Holdings (IMCR) Share-based Compensation (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Immunocore Holdings reported Share-based Compensation of $33.88 million, down 2.5% year-over-year; for FY2025, it was $37.7 million, up 10.3% from FY2024.

  • Share-based Compensation carries a five-year compound annual growth rate of 28.5% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $34.19 million in FY2024 (+5.3%), $32.47 million in FY2023 (-1.3%), $32.89 million in FY2022 (-32.7%) and $48.89 million in FY2021 (+353.7%).
  • The five-year range for quarterly Share-based Compensation is $6.3 million (Q1 2026) to $12.68 million (Q3 2021).
  • Year-over-year, Share-based Compensation has declined for three consecutive quarters, with growth averaging 1.6% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q3 2025 (growth of 50.0%), and the weakest in Q3 2022 (a decline of 43.4%).
  • Business Quant data shows IMCR's Share-based Compensation at $6.3 million (Q1 2026), $8.34 million (Q4 2025) and $9.84 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Immunocore Holdings 1.58 Bn -1.90 Bn 114.84 Mn 9.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.40 Mn
Mar 31, 2026 6.30 Mn
Dec 31, 2025 8.34 Mn
Sep 30, 2025 9.84 Mn
Jun 30, 2025 10.03 Mn
Mar 31, 2025 9.49 Mn
Dec 31, 2024 8.67 Mn
Sep 30, 2024 6.56 Mn
Jun 30, 2024 10.00 Mn
Mar 31, 2024 8.96 Mn
Dec 31, 2023 7.19 Mn
Sep 30, 2023 8.20 Mn
Jun 30, 2023 8.75 Mn
Mar 31, 2023 8.26 Mn
Dec 31, 2022 8.06 Mn
Sep 30, 2022 7.18 Mn
Jun 30, 2022 9.34 Mn
Dec 31, 2021 11.76 Mn
Sep 30, 2021 12.68 Mn
API Access

Immunocore Holdings Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMCR&period=max&api_key=YOUR_API_KEY